Aydın Omay, B. Et Al. 2022. Cross-talk of cholinergic and beta-adrenergic receptor signalling in chronic myeloid leukemia K562 cells. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.49, no.4 , 515-524.

Aydın Omay, B., Gören, M. Z., Kanli, Z., & Cabadak, H., (2022). Cross-talk of cholinergic and beta-adrenergic receptor signalling in chronic myeloid leukemia K562 cells. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.49, no.4, 515-524.

Aydın Omay, BANU Et Al. "Cross-talk of cholinergic and beta-adrenergic receptor signalling in chronic myeloid leukemia K562 cells," CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.49, no.4, 515-524, 2022

Aydın Omay, BANU A. Et Al. "Cross-talk of cholinergic and beta-adrenergic receptor signalling in chronic myeloid leukemia K562 cells." CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.49, no.4, pp.515-524, 2022

Aydın Omay, B. Et Al. (2022) . "Cross-talk of cholinergic and beta-adrenergic receptor signalling in chronic myeloid leukemia K562 cells." CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.49, no.4, pp.515-524.

@article{article, author={BANU AYDIN OMAY Et Al. }, title={Cross-talk of cholinergic and beta-adrenergic receptor signalling in chronic myeloid leukemia K562 cells}, journal={CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY}, year=2022, pages={515-524} }